Vimal Mehta | Chief Executive Officer |
Michael Stanton | Controller |
Rob Risinger | Senior Vice President-Clinical Development |
Will Kane | Chief Commercial Officer |
Reina Benabou | Chief Development Officer |
Geoff Meacham | Bank of America |
Robyn Karnauskas | Truist Securities |
Yatin Suneja | Guggenheim Partners |
Sumant Kulkarni | Canaccord |
Ram Selvaraju | H.C. Wainwright |
Hello, and welcome to the BioXcel Therapeutics Second Quarter 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to Vimal Mehta, CEO.